An international team of researchers recently concluded that men with primary biliary cholangitis (PBC) have more-severe progression of their disease—with worse outcomes—compared to women with PBC. In ...

The cholangitis infection is often caused by bacteria, a gallstone or any another blockage. Primary biliary cholangitis is a chronic condition where inflammation of the bile duct system keeps bile ...

Seladelpar is an oral, selective peroxisome proliferator-activated receptor delta agonist. Treatment with seladelpar was associated with an improvement in cholestatis markers in patients with primary ...

S ince there’s no cure for primary biliary cholangitis (PBC), the main treatment goal is to slow disease progression and ease symptoms, such as itching. The good news is that, for most people, the ...

Please provide your email address to receive an email when new articles are posted on . A greater percentage of patients treated with seladelpar achieved biochemical response and normalization of ...

The treatment is expected to reprogram the immune system to induce tolerance to PDC-E2. The Food and Drug Administration (FDA) has granted Fast Track designation to CNP-104 for the treatment of ...

WASHINGTON, DC — Measures of liver stiffness remained stable or improved in patients with primary biliary cholangitis (PBC) after 36 months of treatment with seladelpar (Livdelzi) based on new data ...

Cholestatic pruritus is a type of itching that can affect people with a liver condition called primary biliary cholangitis (PBC). It is often described as an internal itch that cannot be relieved by ...